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Purpose of the study
Administration of zidovudine (AZT) to patients infected
with the Human Immunodeficiency Virus (HIV) is associ-
ated with anemia and leukopenia. The presence of anemia
is correlated with quality of life and mortality in HIV-
infected patients. Our objective was to investigate the
effect of switching from AZT to alternative antiretroviral
therapy on hematological parameters in HIV-infected
patients.
Methods
Retrospectively, patients were selected who switched from
AZT to either abacavir (ABC) or tenofovir disoproxil
fumarate (TDF) between 2003 and 2007. Hematological
parameters were compared pre-switch and post-switch
using a within subjects design.
Summary of results
Hemoglobin (Hb) levels and leukocyte counts showed
significant mean increases after switch of 0.6 mmol/L and
0.7 109 cells/L, respectively. The prevalence of anemia
dropped from 40.5% to 15.2% and the prevalence of leu-
kopenia from 19.5% to 11.7%. There were no differences
between switching to ABC or TDF.
Conclusion
With this study we confirmed that switching antiretroviral
medication from AZT to either ABC or TDF results in a sig-
nificant increase in Hb and leukocyte count in HIV-
infected patients.
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